undamentalytics Newsletter
Sign in

Lensar, Inc. key statistics and ratios

In fiscal 2025, Lensar, Inc. had an operating margin of -42.1% and a current ratio of 1.15. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Gross margin43.3%53.4%51.8%56.4%50.1%48.3%46.4%48.3%
Operating margin−41.6%−70.1%−57.0%−57.1%−29.0%−19.9%−42.1%−13.5%
Net margin−48.0%−75.0%−56.9%−56.3%−34.1%−58.7%−58.7%57.6%
Free-cash-flow margin−42.5%−53.7%−27.1%−42.3%−23.5%−4.5%−25.5%−12.1%
Return on equity—−107.9%−32.1%−41.1%−38.1%−164.0%——
Return on assets−42.4%−34.8%−26.9%−32.6%−22.9%−46.2%−49.8%49.2%
Asset turnover0.880.460.470.580.670.790.850.85
Current ratio2.196.905.142.953.992.801.152.39
Debt to equity—0.0%0.0%0.0%0.0%0.0%—25.2%
Interest cover (operating income ÷ interest)n/mn/m——————
R&D as % of revenue24.8%28.6%35.9%33.4%14.6%10.0%9.6%8.8%
SG&A as % of revenue56.2%90.1%69.3%76.8%61.9%49.5%77.3%51.5%
Capital spending as % of revenue1.3%1.4%1.0%0.3%0.6%0.3%0.1%0.0%
Free cash flow ÷ net income———————−21.0%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

5 of 6 checks passed · June 30, 2026
What it owns · $70m
Short-term assets $47mLonger-term assets $23m
What it owes, and who funded it · $56m
Short-term liabilities $20mLonger-term liabilities $21mShareholders' equity $15m
  • Short-term assets cover short-term liabilities $47m of assets due within a year against $20m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $47m short-term assets against $21m of longer-dated liabilities.
  • More cash than debt $14m of cash against $4m of debt.
  • Debt below 40% of shareholders' equity Debt is 25% of equity.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt −$7m of operating cash flow against $4m of debt.
  • Operating profit covers interest at least five times over No material interest expense reported.

From Lensar, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

32 /100

Weak moat

How hard Lensar's competitive advantage looks for rivals to wear away, judged from 7 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -11.8% of total assets over 6 years.

  • Pricing power 16 / 20

    Gross margin has been a median 49.9%, moving by 3.3 percentage points (standard deviation) across 7 years.

  • Durability 10 / 20

    Operating margin has been a median -36.4%; its worst year was -69.5%.

  • Cash conversion 0 / 20

    Free cash flow was positive in 0 of 6 years, at a median -22.8% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: CVRX vs LNSRAPT vs LNSRAPYX vs LNSR

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Lensar, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Lensar, Inc.